CAC Nantong Chemical Co Ltd (301665.SZ)
Nantong, CN
CAC Nantong Chemical Co., Ltd. specializes in the research, development, manufacturing, and global distribution of crop protection products, encompassing pesticides and a variety of functional chemicals. Its commercial reach spans China, North America, South America, Europe, and Southeast Asia. The company's offerings include pesticide technical products like chlorothalonil, 2,4-D, azoxystrobin, and thiocarbamate, as well as material intermediates such as MXDA and 4E. Additionally, it provides specialty chemicals, including curing agents, agrochemical and pharmaceutical intermediates, corrosion inhibitors, photo initiators, and nylon. Founded in Nantong, China, in 1992, CAC Nantong Chemical Co., Ltd. operates as a subsidiary of Tahoe Group Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60% | -5.96% | -14.97% | -27.33% | -21.28% | -17.35% | -20.23% | -41.72% | -41.72% | -41.72% | -41.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Agricultural Inputs: +9.5%+26.7% ★ Q1'26: +33.4% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+62.1% ★ Q1'26: +57.9% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+4.6% Q1'26: +4.3% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+14.5% ★ Q1'26: +15.5% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+15.5% ★ Q1'26: +14.3% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+8.0% Q1'26: +8.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.93× Q1'26: 1.54× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
5.37B
est: 5.14B (+4.5%)
|
6.08B
6.08B – 6.08B
+18.3% YoY
|
6.96B
6.96B – 6.96B
+14.6% YoY
|
7.64B
7.64B – 7.64B
+9.7% YoY
|
| EBITDA |
1.04B
est: 933.41M (+10.9%)
|
1.10B
1.10B – 1.10B
+18.3% YoY
|
1.26B
1.26B – 1.26B
+14.6% YoY
|
1.39B
1.39B – 1.39B
+9.7% YoY
|
| EBIT |
776.45M
est: 680.44M (+14.1%)
|
804.67M
804.67M – 804.67M
+18.3% YoY
|
921.87M
921.87M – 921.87M
+14.6% YoY
|
1.01B
1.01B – 1.01B
+9.7% YoY
|
| Net Income |
465.75M
est: 439.63M (+5.9%)
|
544.10M
544.10M – 544.10M
+23.8% YoY
|
661.63M
661.63M – 661.63M
+21.6% YoY
|
800.92M
800.92M – 800.92M
+21.1% YoY
|
| SGA |
193.02M
est: 312.60M (-38.3%)
|
369.67M
369.67M – 369.67M
+18.3% YoY
|
423.52M
423.52M – 423.52M
+14.6% YoY
|
464.77M
464.77M – 464.77M
+9.7% YoY
|
| EPS |
1.07
est: 1.01 (+5.9%)
|
1.25
1.25 – 1.25
+23.8% YoY
|
1.52
1.52 – 1.52
+21.6% YoY
|
1.84
1.84 – 1.84
+21.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| He Li Geng | Chief Agronomist | — | — |
| Hong Hua | Financial Director | — | female |
| Hua Qing Feng | Human Resources Manager & Supervisor | — | male |
| Huai Lin Pang | Deputy GM, Director of Technology Center & Director | — | male |
| Meimin Sun | Deputy GM & Director | — | female |
| Qing Hu | President of Chemical Division | — | — |
| Si Mian Xie | GM & Director | — | male |
| Wen Feng Zhuo | President of New Energy & New Materials Division | — | — |
| Yang Yu | Director of Global Market Strategy & Partnership Development and Director | — | female |
| Yi Yang | Employee Representative Supervisor & Manager of Operations Management Department | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 301665.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
